Published in Blood Weekly, July 12th, 2007
The program is being offered by The Leukemia & Lymphoma Society, the leading source of information and support for patients battling leukemia, lymphoma and myeloma, and is supported by an unrestricted educational grant from Cephalon Oncology and Biogen Idec.
Dr. Byrd is an associate professor of Internal Medicine and director of Hematologic Malignancy at Ohio State...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.